Summary
Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.
According to APO Research, The global Tigecycline market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tigecycline is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Tigecycline is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Tigecycline is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Tigecycline is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Tigecycline include Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, Jiangsu Hansoh Pharmaceutical, Abbott, Natco Pharma, Lyka Labs Limited, Fresenius Kabi and Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tigecycline, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tigecycline, also provides the sales of main regions and countries. Of the upcoming market potential for Tigecycline, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tigecycline sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tigecycline market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tigecycline sales, projected growth trends, production technology, application and end-user industry.
Tigecycline segment by Company
Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals
Tigecycline segment by Type
Original Drug
Generic Drug
Tigecycline segment by Application
Hospital Pharmacies
Retail Pharmacies
Tigecycline segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tigecycline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tigecycline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tigecycline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tigecycline in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tigecycline manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tigecycline sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Tigecycline Market by Type
1.2.1 Global Tigecycline Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Tigecycline Market by Application
1.3.1 Global Tigecycline Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Tigecycline Market Dynamics
2.1 Tigecycline Industry Trends
2.2 Tigecycline Industry Drivers
2.3 Tigecycline Industry Opportunities and Challenges
2.4 Tigecycline Industry Restraints
3 Global Market Growth Prospects
3.1 Global Tigecycline Revenue Estimates and Forecasts (2019-2030)
3.2 Global Tigecycline Revenue by Region
3.2.1 Global Tigecycline Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Tigecycline Revenue by Region (2019-2024)
3.2.3 Global Tigecycline Revenue by Region (2025-2030)
3.2.4 Global Tigecycline Revenue Market Share by Region (2019-2030)
3.3 Global Tigecycline Sales Estimates and Forecasts 2019-2030
3.4 Global Tigecycline Sales by Region
3.4.1 Global Tigecycline Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Tigecycline Sales by Region (2019-2024)
3.4.3 Global Tigecycline Sales by Region (2025-2030)
3.4.4 Global Tigecycline Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Tigecycline Revenue by Manufacturers
4.1.1 Global Tigecycline Revenue by Manufacturers (2019-2024)
4.1.2 Global Tigecycline Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Tigecycline Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Tigecycline Sales by Manufacturers
4.2.1 Global Tigecycline Sales by Manufacturers (2019-2024)
4.2.2 Global Tigecycline Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Tigecycline Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Tigecycline Sales Price by Manufacturers (2019-2024)
4.4 Global Tigecycline Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Tigecycline Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Tigecycline Manufacturers, Product Type & Application
4.7 Global Tigecycline Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Tigecycline Market CR5 and HHI
4.8.2 2023 Tigecycline Tier 1, Tier 2, and Tier 3
5 Tigecycline Market by Type
5.1 Global Tigecycline Revenue by Type
5.1.1 Global Tigecycline Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Tigecycline Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Tigecycline Revenue Market Share by Type (2019-2030)
5.2 Global Tigecycline Sales by Type
5.2.1 Global Tigecycline Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Tigecycline Sales by Type (2019-2030) & (K Units)
5.2.3 Global Tigecycline Sales Market Share by Type (2019-2030)
5.3 Global Tigecycline Price by Type
6 Tigecycline Market by Application
6.1 Global Tigecycline Revenue by Application
6.1.1 Global Tigecycline Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Tigecycline Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Tigecycline Revenue Market Share by Application (2019-2030)
6.2 Global Tigecycline Sales by Application
6.2.1 Global Tigecycline Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Tigecycline Sales by Application (2019-2030) & (K Units)
6.2.3 Global Tigecycline Sales Market Share by Application (2019-2030)
6.3 Global Tigecycline Price by Application
7 Company Profiles
7.1 Pfizer (Wyeth)
7.1.1 Pfizer (Wyeth) Comapny Information
7.1.2 Pfizer (Wyeth) Business Overview
7.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Pfizer (Wyeth) Tigecycline Product Portfolio
7.1.5 Pfizer (Wyeth) Recent Developments
7.2 Sino Biopharmaceutical
7.2.1 Sino Biopharmaceutical Comapny Information
7.2.2 Sino Biopharmaceutical Business Overview
7.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Sino Biopharmaceutical Tigecycline Product Portfolio
7.2.5 Sino Biopharmaceutical Recent Developments
7.3 Zhejiang Hisun Pharma
7.3.1 Zhejiang Hisun Pharma Comapny Information
7.3.2 Zhejiang Hisun Pharma Business Overview
7.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Zhejiang Hisun Pharma Tigecycline Product Portfolio
7.3.5 Zhejiang Hisun Pharma Recent Developments
7.4 Jiangsu Hansoh Pharmaceutical
7.4.1 Jiangsu Hansoh Pharmaceutical Comapny Information
7.4.2 Jiangsu Hansoh Pharmaceutical Business Overview
7.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio
7.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments
7.5 Abbott
7.5.1 Abbott Comapny Information
7.5.2 Abbott Business Overview
7.5.3 Abbott Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Abbott Tigecycline Product Portfolio
7.5.5 Abbott Recent Developments
7.6 Natco Pharma
7.6.1 Natco Pharma Comapny Information
7.6.2 Natco Pharma Business Overview
7.6.3 Natco Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Natco Pharma Tigecycline Product Portfolio
7.6.5 Natco Pharma Recent Developments
7.7 Lyka Labs Limited
7.7.1 Lyka Labs Limited Comapny Information
7.7.2 Lyka Labs Limited Business Overview
7.7.3 Lyka Labs Limited Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Lyka Labs Limited Tigecycline Product Portfolio
7.7.5 Lyka Labs Limited Recent Developments
7.8 Fresenius Kabi
7.8.1 Fresenius Kabi Comapny Information
7.8.2 Fresenius Kabi Business Overview
7.8.3 Fresenius Kabi Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Fresenius Kabi Tigecycline Product Portfolio
7.8.5 Fresenius Kabi Recent Developments
7.9 Sandoz
7.9.1 Sandoz Comapny Information
7.9.2 Sandoz Business Overview
7.9.3 Sandoz Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Sandoz Tigecycline Product Portfolio
7.9.5 Sandoz Recent Developments
7.10 APOTEX
7.10.1 APOTEX Comapny Information
7.10.2 APOTEX Business Overview
7.10.3 APOTEX Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 APOTEX Tigecycline Product Portfolio
7.10.5 APOTEX Recent Developments
7.11 Accord Healthcare
7.11.1 Accord Healthcare Comapny Information
7.11.2 Accord Healthcare Business Overview
7.11.3 Accord Healthcare Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Accord Healthcare Tigecycline Product Portfolio
7.11.5 Accord Healthcare Recent Developments
7.12 Amneal Pharmaceuticals
7.12.1 Amneal Pharmaceuticals Comapny Information
7.12.2 Amneal Pharmaceuticals Business Overview
7.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Amneal Pharmaceuticals Tigecycline Product Portfolio
7.12.5 Amneal Pharmaceuticals Recent Developments
8 North America
8.1 North America Tigecycline Market Size by Type
8.1.1 North America Tigecycline Revenue by Type (2019-2030)
8.1.2 North America Tigecycline Sales by Type (2019-2030)
8.1.3 North America Tigecycline Price by Type (2019-2030)
8.2 North America Tigecycline Market Size by Application
8.2.1 North America Tigecycline Revenue by Application (2019-2030)
8.2.2 North America Tigecycline Sales by Application (2019-2030)
8.2.3 North America Tigecycline Price by Application (2019-2030)
8.3 North America Tigecycline Market Size by Country
8.3.1 North America Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Tigecycline Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Tigecycline Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Tigecycline Market Size by Type
9.1.1 Europe Tigecycline Revenue by Type (2019-2030)
9.1.2 Europe Tigecycline Sales by Type (2019-2030)
9.1.3 Europe Tigecycline Price by Type (2019-2030)
9.2 Europe Tigecycline Market Size by Application
9.2.1 Europe Tigecycline Revenue by Application (2019-2030)
9.2.2 Europe Tigecycline Sales by Application (2019-2030)
9.2.3 Europe Tigecycline Price by Application (2019-2030)
9.3 Europe Tigecycline Market Size by Country
9.3.1 Europe Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Tigecycline Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Tigecycline Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Tigecycline Market Size by Type
10.1.1 China Tigecycline Revenue by Type (2019-2030)
10.1.2 China Tigecycline Sales by Type (2019-2030)
10.1.3 China Tigecycline Price by Type (2019-2030)
10.2 China Tigecycline Market Size by Application
10.2.1 China Tigecycline Revenue by Application (2019-2030)
10.2.2 China Tigecycline Sales by Application (2019-2030)
10.2.3 China Tigecycline Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Tigecycline Market Size by Type
11.1.1 Asia Tigecycline Revenue by Type (2019-2030)
11.1.2 Asia Tigecycline Sales by Type (2019-2030)
11.1.3 Asia Tigecycline Price by Type (2019-2030)
11.2 Asia Tigecycline Market Size by Application
11.2.1 Asia Tigecycline Revenue by Application (2019-2030)
11.2.2 Asia Tigecycline Sales by Application (2019-2030)
11.2.3 Asia Tigecycline Price by Application (2019-2030)
11.3 Asia Tigecycline Market Size by Country
11.3.1 Asia Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Tigecycline Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Tigecycline Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Tigecycline Market Size by Type
12.1.1 MEALA Tigecycline Revenue by Type (2019-2030)
12.1.2 MEALA Tigecycline Sales by Type (2019-2030)
12.1.3 MEALA Tigecycline Price by Type (2019-2030)
12.2 MEALA Tigecycline Market Size by Application
12.2.1 MEALA Tigecycline Revenue by Application (2019-2030)
12.2.2 MEALA Tigecycline Sales by Application (2019-2030)
12.2.3 MEALA Tigecycline Price by Application (2019-2030)
12.3 MEALA Tigecycline Market Size by Country
12.3.1 MEALA Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Tigecycline Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Tigecycline Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Tigecycline Value Chain Analysis
13.1.1 Tigecycline Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Tigecycline Production Mode & Process
13.2 Tigecycline Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Tigecycline Distributors
13.2.3 Tigecycline Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Tigecycline Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Original Drug Major Manufacturers
Table 3. Generic Drug Major Manufacturers
Table 4. Global Tigecycline Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Hospital Pharmacies Major Manufacturers
Table 6. Retail Pharmacies Major Manufacturers
Table 7. Tigecycline Industry Trends
Table 8. Tigecycline Industry Drivers
Table 9. Tigecycline Industry Opportunities and Challenges
Table 10. Tigecycline Industry Restraints
Table 11. Global Tigecycline Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Tigecycline Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Tigecycline Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Tigecycline Revenue Market Share by Region (2019-2024)
Table 15. Global Tigecycline Revenue Market Share by Region (2025-2030)
Table 16. Global Tigecycline Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 17. Global Tigecycline Sales by Region (2019-2024) & (K Units)
Table 18. Global Tigecycline Sales by Region (2025-2030) & (K Units)
Table 19. Global Tigecycline Sales Market Share by Region (2019-2024)
Table 20. Global Tigecycline Sales Market Share by Region (2025-2030)
Table 21. Global Tigecycline Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Tigecycline Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Tigecycline Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Tigecycline Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Tigecycline Sales Price (USD/Unit) of Manufacturers (2019-2024)
Table 26. Global Tigecycline Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Tigecycline Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Tigecycline Manufacturers, Product Type & Application
Table 29. Global Tigecycline Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Tigecycline by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Tigecycline Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Tigecycline Revenue Market Share by Type (2019-2024)
Table 36. Global Tigecycline Revenue Market Share by Type (2025-2030)
Table 37. Global Tigecycline Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 38. Global Tigecycline Sales by Type (2019-2024) & (K Units)
Table 39. Global Tigecycline Sales by Type (2025-2030) & (K Units)
Table 40. Global Tigecycline Sales Market Share by Type (2019-2024)
Table 41. Global Tigecycline Sales Market Share by Type (2025-2030)
Table 42. Global Tigecycline Price by Type (2019-2024) & (USD/Unit)
Table 43. Global Tigecycline Price by Type (2025-2030) & (USD/Unit)
Table 44. Global Tigecycline Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Tigecycline Revenue Market Share by Application (2019-2024)
Table 48. Global Tigecycline Revenue Market Share by Application (2025-2030)
Table 49. Global Tigecycline Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 50. Global Tigecycline Sales by Application (2019-2024) & (K Units)
Table 51. Global Tigecycline Sales by Application (2025-2030) & (K Units)
Table 52. Global Tigecycline Sales Market Share by Application (2019-2024)
Table 53. Global Tigecycline Sales Market Share by Application (2025-2030)
Table 54. Global Tigecycline Price by Application (2019-2024) & (USD/Unit)
Table 55. Global Tigecycline Price by Application (2025-2030) & (USD/Unit)
Table 56. Pfizer (Wyeth) Company Information
Table 57. Pfizer (Wyeth) Business Overview
Table 58. Pfizer (Wyeth) Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 59. Pfizer (Wyeth) Tigecycline Product Portfolio
Table 60. Pfizer (Wyeth) Recent Development
Table 61. Sino Biopharmaceutical Company Information
Table 62. Sino Biopharmaceutical Business Overview
Table 63. Sino Biopharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Sino Biopharmaceutical Tigecycline Product Portfolio
Table 65. Sino Biopharmaceutical Recent Development
Table 66. Zhejiang Hisun Pharma Company Information
Table 67. Zhejiang Hisun Pharma Business Overview
Table 68. Zhejiang Hisun Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Zhejiang Hisun Pharma Tigecycline Product Portfolio
Table 70. Zhejiang Hisun Pharma Recent Development
Table 71. Jiangsu Hansoh Pharmaceutical Company Information
Table 72. Jiangsu Hansoh Pharmaceutical Business Overview
Table 73. Jiangsu Hansoh Pharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio
Table 75. Jiangsu Hansoh Pharmaceutical Recent Development
Table 76. Abbott Company Information
Table 77. Abbott Business Overview
Table 78. Abbott Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Abbott Tigecycline Product Portfolio
Table 80. Abbott Recent Development
Table 81. Natco Pharma Company Information
Table 82. Natco Pharma Business Overview
Table 83. Natco Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Natco Pharma Tigecycline Product Portfolio
Table 85. Natco Pharma Recent Development
Table 86. Lyka Labs Limited Company Information
Table 87. Lyka Labs Limited Business Overview
Table 88. Lyka Labs Limited Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Lyka Labs Limited Tigecycline Product Portfolio
Table 90. Lyka Labs Limited Recent Development
Table 91. Fresenius Kabi Company Information
Table 92. Fresenius Kabi Business Overview
Table 93. Fresenius Kabi Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Fresenius Kabi Tigecycline Product Portfolio
Table 95. Fresenius Kabi Recent Development
Table 96. Sandoz Company Information
Table 97. Sandoz Business Overview
Table 98. Sandoz Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sandoz Tigecycline Product Portfolio
Table 100. Sandoz Recent Development
Table 101. APOTEX Company Information
Table 102. APOTEX Business Overview
Table 103. APOTEX Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. APOTEX Tigecycline Product Portfolio
Table 105. APOTEX Recent Development
Table 106. Accord Healthcare Company Information
Table 107. Accord Healthcare Business Overview
Table 108. Accord Healthcare Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Accord Healthcare Tigecycline Product Portfolio
Table 110. Accord Healthcare Recent Development
Table 111. Amneal Pharmaceuticals Company Information
Table 112. Amneal Pharmaceuticals Business Overview
Table 113. Amneal Pharmaceuticals Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Amneal Pharmaceuticals Tigecycline Product Portfolio
Table 115. Amneal Pharmaceuticals Recent Development
Table 116. North America Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 117. North America Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 118. North America Tigecycline Sales by Type (2019-2024) & (K Units)
Table 119. North America Tigecycline Sales by Type (2025-2030) & (K Units)
Table 120. North America Tigecycline Sales Price by Type (2019-2024) & (USD/Unit)
Table 121. North America Tigecycline Sales Price by Type (2025-2030) & (USD/Unit)
Table 122. North America Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 123. North America Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 124. North America Tigecycline Sales by Application (2019-2024) & (K Units)
Table 125. North America Tigecycline Sales by Application (2025-2030) & (K Units)
Table 126. North America Tigecycline Sales Price by Application (2019-2024) & (USD/Unit)
Table 127. North America Tigecycline Sales Price by Application (2025-2030) & (USD/Unit)
Table 128. North America Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 129. North America Tigecycline Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 130. North America Tigecycline Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 131. North America Tigecycline Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 132. North America Tigecycline Sales by Country (2019-2024) & (K Units)
Table 133. North America Tigecycline Sales by Country (2025-2030) & (K Units)
Table 134. North America Tigecycline Sales Price by Country (2019-2024) & (USD/Unit)
Table 135. North America Tigecycline Sales Price by Country (2025-2030) & (USD/Unit)
Table 136. US Tigecycline Revenue (2019-2030) & (US$ Million)
Table 137. Canada Tigecycline Revenue (2019-2030) & (US$ Million)
Table 138. Europe Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 139. Europe Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 140. Europe Tigecycline Sales by Type (2019-2024) & (K Units)
Table 141. Europe Tigecycline Sales by Type (2025-2030) & (K Units)
Table 142. Europe Tigecycline Sales Price by Type (2019-2024) & (USD/Unit)
Table 143. Europe Tigecycline Sales Price by Type (2025-2030) & (USD/Unit)
Table 144. Europe Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 145. Europe Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 146. Europe Tigecycline Sales by Application (2019-2024) & (K Units)
Table 147. Europe Tigecycline Sales by Application (2025-2030) & (K Units)
Table 148. Europe Tigecycline Sales Price by Application (2019-2024) & (USD/Unit)
Table 149. Europe Tigecycline Sales Price by Application (2025-2030) & (USD/Unit)
Table 150. Europe Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 151. Europe Tigecycline Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 152. Europe Tigecycline Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 153. Europe Tigecycline Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 154. Europe Tigecycline Sales by Country (2019-2024) & (K Units)
Table 155. Europe Tigecycline Sales by Country (2025-2030) & (K Units)
Table 156. Europe Tigecycline Sales Price by Country (2019-2024) & (USD/Unit)
Table 157. Europe Tigecycline Sales Price by Country (2025-2030) & (USD/Unit)
Table 158. Germany Tigecycline Revenue (2019-2030) & (US$ Million)
Table 159. France Tigecycline Revenue (2019-2030) & (US$ Million)
Table 160. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 161. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 162. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 163. China Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 164. China Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 165. China Tigecycline Sales by Type (2019-2024) & (K Units)
Table 166. China Tigecycline Sales by Type (2025-2030) & (K Units)
Table 167. China Tigecycline Sales Price by Type (2019-2024) & (USD/Unit)
Table 168. China Tigecycline Sales Price by Type (2025-2030) & (USD/Unit)
Table 169. China Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 170. China Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 171. China Tigecycline Sales by Application (2019-2024) & (K Units)
Table 172. China Tigecycline Sales by Application (2025-2030) & (K Units)
Table 173. China Tigecycline Sales Price by Application (2019-2024) & (USD/Unit)
Table 174. China Tigecycline Sales Price by Application (2025-2030) & (USD/Unit)
Table 175. Asia Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 176. Asia Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 177. Asia Tigecycline Sales by Type (2019-2024) & (K Units)
Table 178. Asia Tigecycline Sales by Type (2025-2030) & (K Units)
Table 179. Asia Tigecycline Sales Price by Type (2019-2024) & (USD/Unit)
Table 180. Asia Tigecycline Sales Price by Type (2025-2030) & (USD/Unit)
Table 181. Asia Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 182. Asia Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 183. Asia Tigecycline Sales by Application (2019-2024) & (K Units)
Table 184. Asia Tigecycline Sales by Application (2025-2030) & (K Units)
Table 185. Asia Tigecycline Sales Price by Application (2019-2024) & (USD/Unit)
Table 186. Asia Tigecycline Sales Price by Application (2025-2030) & (USD/Unit)
Table 187. Asia Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 188. Asia Tigecycline Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 189. Asia Tigecycline Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 190. Asia Tigecycline Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 191. Asia Tigecycline Sales by Country (2019-2024) & (K Units)
Table 192. Asia Tigecycline Sales by Country (2025-2030) & (K Units)
Table 193. Asia Tigecycline Sales Price by Country (2019-2024) & (USD/Unit)
Table 194. Asia Tigecycline Sales Price by Country (2025-2030) & (USD/Unit)
Table 195. Japan Tigecycline Revenue (2019-2030) & (US$ Million)
Table 196. South Korea Tigecycline Revenue (2019-2030) & (US$ Million)
Table 197. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 198. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 199. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 200. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 201. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 202. Tigecycline Revenue (2019-2030) & (US$ Million)
Table 203. MEALA Tigecycline Revenue by Type (2019-2024) & (US$ Million)
Table 204. MEALA Tigecycline Revenue by Type (2025-2030) & (US$ Million)
Table 205. MEALA Tigecycline Sales by Type (2019-2024) & (K Units)
Table 206. MEALA Tigecycline Sales by Type (2025-2030) & (K Units)
Table 207. MEALA Tigecycline Sales Price by Type (2019-2024) & (USD/Unit)
Table 208. MEALA Tigecycline Sales Price by Type (2025-2030) & (USD/Unit)
Table 209. MEALA Tigecycline Revenue by Application (2019-2024) & (US$ Million)
Table 210. MEALA Tigecycline Revenue by Application (2025-2030) & (US$ Million)
Table 211. MEALA Tigecycline Sales by Application (2019-2024) & (K Units)
Table 212. MEALA Tigecycline Sales by Application (2025-2030) & (K Units)
Table 213. MEALA Tigecycline Sales Price by Application (2019-2024) & (USD/Unit)
Table 214. MEALA Tigecycline Sales Price by Application (2025-2030) & (USD/Unit)
Table 215. MEALA Tigecycline Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 216. MEALA Tigecycline Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 217. MEALA Tigecycline Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 218. MEALA Tigecycline Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 219. MEALA Tigecycline Sales by Country (2019-2024) & (K Units)
Table 220. MEALA Tigecycline Sales by Country (2025-2030) & (K Units)
Table 221. MEALA Tigecycline Sales Price by Country (2019-2024) & (USD/Unit)
Table 222. MEALA Tigecycline Sales Price by Country (2025-2030) & (USD/Unit)
Table 223. Mexico Tigecycline Revenue (2019-2030) & (US$ Million)
Table 224. Brazil Tigecycline Revenue (2019-2030) & (US$ Million)
Table 225. Israel Tigecycline Revenue (2019-2030) & (US$ Million)
Table 226. Argentina Tigecycline Revenue (2019-2030) & (US$ Million)
Table 227. Colombia Tigecycline Revenue (2019-2030) & (US$ Million)
Table 228. Turkey Tigecycline Revenue (2019-2030) & (US$ Million)
Table 229. Saudi Arabia Tigecycline Revenue (2019-2030) & (US$ Million)
Table 230. UAE Tigecycline Revenue (2019-2030) & (US$ Million)
Table 231. Key Raw Materials
Table 232. Raw Materials Key Suppliers
Table 233. Tigecycline Distributors List
Table 234. Tigecycline Customers List
Table 235. Research Programs/Design for This Report
Table 236. Authors List of This Report
Table 237. Secondary Sources
Table 238. Primary Sources
List of Figures
Figure 1. Tigecycline Product Picture
Figure 2. Global Tigecycline Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Tigecycline Market Size Share 2019 VS 2023 VS 2030
Figure 4. Original Drug Picture
Figure 5. Generic Drug Picture
Figure 6. Global Tigecycline Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Tigecycline Market Size Share 2019 VS 2023 VS 2030
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Tigecycline Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Tigecycline Revenue (2019-2030) & (US$ Million)
Figure 12. Global Tigecycline Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Tigecycline Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Tigecycline Revenue Market Share by Region (2019-2030)
Figure 15. Global Tigecycline Sales (2019-2030) & (K Units)
Figure 16. Global Tigecycline Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 17. Global Tigecycline Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Tigecycline Sales YoY (2019-2030) & (K Units)
Figure 19. Europe Tigecycline Sales YoY (2019-2030) & (K Units)
Figure 20. China Tigecycline Sales YoY (2019-2030) & (K Units)
Figure 21. Asia (Excluding China) Tigecycline Sales YoY (2019-2030) & (K Units)
Figure 22. Middle East, Africa and Latin America (Excluding China) Tigecycline Sales YoY (2019-2030) & (K Units)
Figure 23. Global Tigecycline Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Tigecycline Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Tigecycline Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Tigecycline Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Tigecycline Revenue Market Share by Type (2019-2030)
Figure 29. Global Tigecycline Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 30. Global Tigecycline Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Tigecycline Sales Market Share by Type (2019-2030)
Figure 32. Global Tigecycline Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Tigecycline Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Tigecycline Revenue Market Share by Application (2019-2030)
Figure 35. Global Tigecycline Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 36. Global Tigecycline Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Tigecycline Sales Market Share by Application (2019-2030)
Figure 38. North America Tigecycline Revenue Share by Type (2019-2030)
Figure 39. North America Tigecycline Sales Share by Type (2019-2030)
Figure 40. North America Tigecycline Revenue Share by Application (2019-2030)
Figure 41. North America Tigecycline Sales Share by Application (2019-2030)
Figure 42. North America Tigecycline Revenue Share by Country (2019-2030)
Figure 43. North America Tigecycline Sales Share by Country (2019-2030)
Figure 44. Europe Tigecycline Revenue Share by Type (2019-2030)
Figure 45. Europe Tigecycline Sales Share by Type (2019-2030)
Figure 46. Europe Tigecycline Revenue Share by Application (2019-2030)
Figure 47. Europe Tigecycline Sales Share by Application (2019-2030)
Figure 48. Europe Tigecycline Revenue Share by Country (2019-2030)
Figure 49. Europe Tigecycline Sales Share by Country (2019-2030)
Figure 50. China Tigecycline Revenue Share by Type (2019-2030)
Figure 51. China Tigecycline Sales Share by Type (2019-2030)
Figure 52. China Tigecycline Revenue Share by Application (2019-2030)
Figure 53. China Tigecycline Sales Share by Application (2019-2030)
Figure 54. Asia Tigecycline Revenue Share by Type (2019-2030)
Figure 55. Asia Tigecycline Sales Share by Type (2019-2030)
Figure 56. Asia Tigecycline Revenue Share by Application (2019-2030)
Figure 57. Asia Tigecycline Sales Share by Application (2019-2030)
Figure 58. Asia Tigecycline Revenue Share by Country (2019-2030)
Figure 59. Asia Tigecycline Sales Share by Country (2019-2030)
Figure 60. MEALA Tigecycline Revenue Share by Type (2019-2030)
Figure 61. MEALA Tigecycline Sales Share by Type (2019-2030)
Figure 62. MEALA Tigecycline Revenue Share by Application (2019-2030)
Figure 63. MEALA Tigecycline Sales Share by Application (2019-2030)
Figure 64. MEALA Tigecycline Revenue Share by Country (2019-2030)
Figure 65. MEALA Tigecycline Sales Share by Country (2019-2030)
Figure 66. Tigecycline Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Tigecycline Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
